Seidel-Dugan Cynthia bought HOWL
January 2, 2024 · Form 4 insider transaction
Seidel-Dugan Cynthia bought 150,000 shares of Werewolf Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderSeidel-Dugan Cynthia
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.